Broker research continues to support the story too... risk adjusted price target of $1.50 ($1.60 pre placement)... They have an unrisked NPV valuation of $11 per share... Not sure what dilution is factored into this... Also worth noting... Both of these numbers are only valuing ARG-007 in Ischemic Stroke... So excludes any value for HIE, TBI or AD (not sure what market value of each of these are.... But safe to say alot more upside to $1.50 as those progress off the back of the Ischemic Strove program... GLTAH.
Broker research continues to support the story too... risk...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
0.025(3.05%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 82.5¢ | 85.0¢ | 81.5¢ | $140.2K | 168.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 82.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 2400 | 1 |
View Market Depth
| Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |